Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
14,97 USD | +1,91 % | +4,98 % | +39,91 % |
02/05 | Immunome, Inc. nombra a Kinney Horn director comercial | CI |
30/04 | IMMUNOME, INC. : recomendación de compra de JPMorgan Chase | ZM |
Resumen de negocios
Número de empleados: 55
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biotechnology
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Clay Siegall
CEO | Chief Executive Officer | 63 | 02/10/23 |
Max Rosett
DFI | Director of Finance/CFO | 34 | 02/10/23 |
Bob Lechleider
CTO | Chief Tech/Sci/R&D Officer | 63 | 19/10/23 |
Matthew Robinson
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/16 |
Jack Higgins
CTO | Chief Tech/Sci/R&D Officer | 45 | 02/10/23 |
Philip Wagenheim
BRD | Director/Board Member | 53 | 01/01/17 |
Robert Lapetina
AUD | Comptroller/Controller/Auditor | 49 | 01/05/21 |
Bruce Turner
PRN | Corporate Officer/Principal | 60 | 02/10/23 |
Sandra Stoneman
LAW | General Counsel | 51 | 10/12/20 |
Kinney Horn
PRN | Corporate Officer/Principal | 49 | 01/02 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 02/01 |
Director/Board Member | 70 | 07/11 | |
Clay Siegall
CEO | Chief Executive Officer | 63 | 02/10/23 |
Philip Wagenheim
BRD | Director/Board Member | 53 | 01/01/17 |
James Boylan
BRD | Director/Board Member | 57 | 02/10/23 |
Isaac Barchas
BRD | Director/Board Member | 56 | 02/10/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 59 943 368 | 49 138 414 ( 81,97 %) | 0 | 81,97 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+39,91 % | 881 M | |
-1,65 % | 104 mil M | |
+6,75 % | 97,47 mil M | |
+5,71 % | 22,25 mil M | |
-12,60 % | 21,68 mil M | |
-9,70 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-10,17 % | 16,36 mil M | |
+6,12 % | 14,39 mil M | |
+35,47 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción IMNM
- Empresa Immunome, Inc.